Methylergonovine Maleate
NDC Package 40032-140-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Methylergonovine Maleate is a medication used after childbirth to help stop bleeding from the uterus. Marketed by Novel Laboratories, Inc., this product is identified by NDC 40032-140 and is authorized under FDA application ANDA091577.

Identification & Billing

NDC Package Code
40032-140-01
Package Description
100 TABLET in 1 BOTTLE
Product Code
40032-140
11-Digit Billing Format
40032014001
RxNorm Crosswalk
RxCUI: 996824 - methylergonovine maleate 0.2 MG Oral Tablet

Clinical Specifications

Proprietary Name
Methylergonovine Maleate
Dosage Form
-
Usage Information
This medication is used after childbirth to help stop bleeding from the uterus. Methylergonovine belongs to a class of drugs known as ergot alkaloids. It works by increasing the rate and strength of contractions and the stiffness of the uterus muscles. These effects help to decrease bleeding.

Regulatory & Marketing

Labeler Name
Novel Laboratories, Inc.
FDA Application #
ANDA091577
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
06-15-2011
Listing Expiration
12-31-2023
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (40032-140). Click a package code to view its specific billing and regulatory data.

40032-140-07
7 TABLET in 1 BOTTLE
40032-140-28
28 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 40032-140-01 identifies a specific commercial package of 100 tablet in 1 bottle of Methylergonovine Maleate, labeled by Novel Laboratories, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Novel Laboratories, Inc. on June 15, 2011. The current certification is valid through December 31, 2023.

What are the primary indications for this medication?

This medication is used after childbirth to help stop bleeding from the uterus. Methylergonovine belongs to a class of drugs known as ergot alkaloids. It works by increasing the rate and strength of contractions and the stiffness of the uterus muscles. These effects help to decrease bleeding.

How is this Novel Laboratories, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 40032014001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
40032-140-01
11-Digit CMS (5-4-2)
40032-0140-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.